NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis

por Richardson, M., Kirkham, J., Dwan, K., Sloan, D. J., Davies, G., Jorgensen, A. L.
Publicado 2019

SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink

por Carr, D F, O'Meara, H, Jorgensen, A L, Campbell, J, Hobbs, M, McCann, G, van Staa, T, Pirmohamed, M
Publicado 2013

Serum and blister‐fluid elevation and decreased epidermal content of high‐mobility group box 1 protein in drug‐induced Stevens–Johnson syndrome/toxic epidermal necrolysis

por Carr, D.F., Wang, C.‐W., Bellón, T., Ressel, L., Nwikue, G., Shrivastava, V., Bergfeld, W., Jorgensen, A.L., Chung, W.‐H., Pirmohamed, M.
Publicado 2019

Biomarker-guided trials: Challenges in practice

por Antoniou, M., Kolamunnage-Dona, R., Wason, J., Bathia, R., Billingham, C., Bliss, J.M., Brown, L.C., Gillman, A., Paul, J., Jorgensen, A.L.
Publicado 2019